The role of BRCA-1 and -2 are most often investigated in the context of hereditary ovarian cancer, but recent reports also highlight the relatively high prevalence of somatic mutations in BRCA-1 and -2 genes and the potential use of individualized therapy for these patients [125,126,127]. Here, BRCA1 is linked to familial ovarian cancer.